Neutropenic sepsis is a life-threatening emergency that occurs when a person with dangerously low white blood cell counts develops an infection that triggers a widespread inflammatory response. It most commonly affects people receiving chemotherapy, which suppresses the bone marrow’s ability to produce neutrophils, the white blood cells responsible for fighting bacterial and fungal infections. With mortality rates ranging from 2% to 21% depending on severity, neutropenic sepsis requires antibiotic treatment within hours of the first sign of fever.
How Neutropenia Sets the Stage
Neutrophils are your body’s first responders to infection. They arrive at the site of a bacterial or fungal invasion, engulf the pathogen, and destroy it. When chemotherapy or other conditions wipe out these cells, even a minor infection that your body would normally handle without you noticing can spiral out of control.
Neutropenia is classified by how far the neutrophil count has dropped. Mild neutropenia falls between 1,000 and 1,500 cells per microliter. Moderate is 500 to 1,000. Severe neutropenia, the level where sepsis risk climbs sharply, is anything below 500 cells per microliter. For context, a healthy adult typically has between 2,500 and 7,000 neutrophils per microliter. At the extreme end, a condition called agranulocytosis (below 200 cells per microliter) leaves virtually no immune defense at all.
What Triggers It
Chemotherapy is by far the most common cause. Cancer-killing drugs damage rapidly dividing cells, and bone marrow cells divide rapidly. The result is a predictable dip in neutrophil counts, usually hitting their lowest point 7 to 14 days after a treatment cycle. During this window, bacteria that normally live harmlessly on your skin, in your mouth, or in your gut can enter the bloodstream and cause overwhelming infection.
The bacteria most often responsible are gram-negative organisms like E. coli, Pseudomonas, and Klebsiella, which together account for the majority of identified infections. Gram-positive bacteria including Staphylococcus species also play a significant role, particularly in patients with central venous catheters. Fungal infections are less common but become a concern when neutropenia lasts longer than 7 to 10 days.
Beyond chemotherapy, neutropenic sepsis can occur in people with bone marrow disorders, those taking certain immunosuppressive medications, or rarely in individuals with inherited conditions that impair neutrophil production.
How It’s Defined and Diagnosed
The formal definition combines two criteria: neutropenia and fever. According to the Infectious Diseases Society of America, febrile neutropenia is a single oral temperature above 38.3°C (101°F), or a sustained temperature above 38°C (100.4°F) for at least one hour, in a patient whose neutrophil count is below 500 cells per microliter. When that fever is accompanied by signs of sepsis (rapid heart rate, low blood pressure, confusion, or organ dysfunction), the diagnosis becomes neutropenic sepsis.
One critical detail: because neutrophils are the cells that produce pus and cause the redness, swelling, and heat you normally associate with infection, a neutropenic patient often lacks these warning signs. A fever may be the only clue that something is seriously wrong. There may be no cough with pneumonia, no redness around a wound, no obvious source of infection at all. This is why any fever in a neutropenic patient is treated as an emergency until proven otherwise.
Initial Testing
When someone presents with suspected neutropenic sepsis, blood is drawn immediately for a complete blood count, kidney and liver function tests, and inflammatory markers. Blood cultures are essential and should be taken from both a peripheral vein and any central line the patient has in place, since the line itself can be the source of infection. Depending on symptoms, urine samples, stool cultures, skin swabs, or imaging may follow to locate the infection’s origin.
Why Speed Matters
Neutropenic sepsis is one of the most time-sensitive emergencies in cancer care. Current guidelines recommend starting broad-spectrum antibiotics within two hours of fever onset. Research consistently shows that mortality rises with each hour of delay. Two studies found a significant increase in death rates specifically correlated to each additional hour before antibiotic administration, and another demonstrated a clear jump in mortality when antibiotics were given after the two-hour mark compared to before it.
The initial antibiotics are chosen to cover a wide range of bacteria, both gram-positive and gram-negative, because there’s no time to wait for culture results to identify the specific organism. Once cultures come back (typically 24 to 48 hours later), the treatment can be narrowed to target the exact pathogen. If fever persists beyond 4 to 7 days despite antibiotics, antifungal treatment is usually added.
Risk Assessment: Who Needs Hospitalization
Not every case of febrile neutropenia carries the same level of danger. Clinicians use scoring systems to separate high-risk patients who need intensive hospital care from lower-risk patients who may be managed with close outpatient monitoring.
The most widely used tool is the MASCC Risk Index, which assigns points based on symptom severity, blood pressure, breathing problems, hydration status, whether the patient was already hospitalized when the fever began, age, and history of prior fungal infections. A score of 21 or higher (out of a maximum 26) indicates lower risk. Patients scoring below 21 are considered high risk and typically require inpatient intravenous antibiotics and close monitoring.
A newer tool called the CISNE score was developed specifically for patients with solid tumors (as opposed to blood cancers). It evaluates six factors: overall functional status, stress-related high blood sugar, active lung disease, heart disease history, mouth sores, and low monocyte counts. A CISNE score of 0 suggests low risk, 1 or 2 is intermediate, and 3 or above is high risk. The two scoring systems look at overlapping but different variables, and many cancer centers use one or both to guide decisions about treatment intensity.
What Recovery Looks Like
For patients who receive prompt treatment, the outlook depends largely on how quickly their neutrophil counts recover. In many cases, the bone marrow begins producing new neutrophils within a few days of the chemotherapy nadir, and once the count rises above 500, the body can begin fighting infection on its own again. Hospital stays for uncomplicated neutropenic sepsis typically last several days but can extend to weeks if the infection is resistant, the source is difficult to control, or organ damage has occurred.
Overall, chemotherapy-treated cancer patients who develop a neutropenic episode face a mortality rate of roughly 17%. That number varies widely based on the type of cancer, the patient’s overall health, and whether the infection progresses to septic shock. Patients with blood cancers and those with prolonged neutropenia lasting more than 7 days tend to have worse outcomes than those with solid tumors and shorter neutropenic windows.
Reducing the Risk
For patients on chemotherapy regimens known to carry a high risk of neutropenia, preventive injections of white blood cell growth factors can stimulate the bone marrow to produce neutrophils more quickly after each treatment cycle. The American Society of Clinical Oncology recommends considering these growth factors based on the chemotherapy regimen’s known risk level and individual patient factors including age 65 or older, frailty, advanced disease, prior chemotherapy or radiation, and preexisting low blood counts or bone marrow involvement by the tumor.
Simple precautions also matter during the high-risk window after chemotherapy. Frequent handwashing, avoiding crowds and people with active infections, careful food handling, and good dental hygiene all reduce the chance that bacteria will gain a foothold when the immune system is at its weakest. Patients are typically told to monitor their temperature regularly and to seek emergency care at the first sign of fever rather than waiting to see if it resolves on its own.